{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:23:00Z","timestamp":1794104580901,"version":"4.8.0"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41581-023-00753-6","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:03:56Z","timestamp":1692806636000},"page":"788-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Primary aldosteronism: molecular medicine meets public health"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-4242","authenticated-orcid":false,"given":"Elena A. B.","family":"Azizan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-1082","authenticated-orcid":false,"given":"Morris J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"753_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02155834","volume":"9","author":"SA Simpson","year":"1953","unstructured":"Simpson, S. A. et al. [Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism]. Experientia 9, 333\u2013335 (1953).","journal-title":"Experientia"},{"key":"753_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","volume":"44","author":"JW Conn","year":"1956","unstructured":"Conn, J. W. & Louis, L. H. Primary aldosteronism, a new clinical entity. Ann. Intern. Med. 44, 1\u201315 (1956).","journal-title":"Ann. Intern. Med."},{"key":"753_CR3","first-page":"187","volume":"2","author":"GS Andersen","year":"1988","unstructured":"Andersen, G. S., Toftdahl, D. B., Lund, J. O., Strandgaard, S. & Nielsen, P. E. The incidence rate of phaeochromocytoma and Conn\u2019s syndrome in Denmark, 1977\u20131981. J. Hum. Hypertens. 2, 187\u2013189 (1988).","journal-title":"J. Hum. Hypertens."},{"key":"753_CR4","first-page":"48","volume":"33","author":"GA Grell","year":"1984","unstructured":"Grell, G. A., Hanchard, B., Fletcher, P. R., Clarke, W. F. & Williams, W. Conn\u2019s syndrome. Case report and a review of the syndrome of primary aldosteronism (SOPA). West Indian Med. J. 33, 48\u201354 (1984).","journal-title":"West Indian Med. J."},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.5694\/j.1326-5377.1961.tb69109.x","volume":"1","author":"F Simpson","year":"1961","unstructured":"Simpson, F. & Barnett, A. Primary aldosteronism (Conn\u2019s syndrome): report of a case, and an analysis of published cases. Med. J. Aust. 1, 729\u2013735 (1961).","journal-title":"Med. J. Aust."},{"key":"753_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ssu.2980060203","volume":"6","author":"RC Merrell","year":"1990","unstructured":"Merrell, R. C. Aldosterone-producing tumors (Conn\u2019s syndrome). Semin. Surg. Oncol. 6, 66\u201370 (1990).","journal-title":"Semin. Surg. Oncol."},{"key":"753_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","volume":"66","author":"NM Kaplan","year":"1967","unstructured":"Kaplan, N. M. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann. Intern. Med. 66, 1079\u20131090 (1967).","journal-title":"Ann. Intern. Med."},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jama.1966.03100010077019","volume":"195","author":"JW Conn","year":"1966","unstructured":"Conn, J. W., Rovner, D. R., Cohen, E. L. & Nesbit, R. M. Normokalemic primary aldosteronism: its masquerade as essential hypertension. JAMA 195, 21\u201326 (1966).","journal-title":"JAMA"},{"key":"753_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi, G. P. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293\u20132300 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"753_CR10","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone, S. et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69, 1811\u20131820 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"753_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M. & Vaidya, A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 6, 51\u201359 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"753_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone, S. et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41\u201350 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2213-8587(18)30174-8","volume":"6","author":"B Williams","year":"2018","unstructured":"Williams, B. & Brown, M. J. Investigation of primary aldosteronism in patients with resistant hypertension \u2014 Authors\u2019 reply. Lancet Diabetes Endocrinol. 6, 600\u2013601 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"753_CR14","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"Mulatero, P. et al. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J. Hypertens. 34, 2253\u20132257 (2016).","journal-title":"J. Hypertens."},{"key":"753_CR15","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JME-17-0035","volume":"59","author":"FL Fernandes-Rosa","year":"2017","unstructured":"Fernandes-Rosa, F. L., Boulkroun, S. & Zennaro, M. C. Somatic and inherited mutations in primary aldosteronism. J. Mol. Endocrinol. 59, R47\u2013R63 (2017).","journal-title":"J. Mol. Endocrinol."},{"key":"753_CR16","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2018-01004","volume":"103","author":"K Nanba","year":"2018","unstructured":"Nanba, K. et al. Targeted molecular characterization of aldosterone-producing adenomas in white Americans. J. Clin. Endocrinol. Metab. 103, 3869\u20133876 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","volume":"75","author":"K De Sousa","year":"2020","unstructured":"De Sousa, K. et al. Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma. Hypertension 75, 1034\u20131044 (2020).","journal-title":"Hypertension"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768\u2013772 (2011).","journal-title":"Science"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","volume":"383","author":"CE Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez, C. E. et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol. Cell Endocrinol. 383, 111\u2013117 (2014).","journal-title":"Mol. Cell Endocrinol."},{"key":"753_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/EJE-10-1085","volume":"164","author":"T Wang","year":"2011","unstructured":"Wang, T. et al. Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur. J. Endocrinol. 164, 613\u2013619 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"753_CR21","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1210\/jc.2011-2965","volume":"97","author":"EA Azizan","year":"2012","unstructured":"Azizan, E. A. et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 97, E819\u2013E829 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EA Azizan","year":"2013","unstructured":"Azizan, E. A. et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat. Genet. 45, 1055\u20131060 (2013).","journal-title":"Nat. Genet."},{"key":"753_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/HYPERTENSIONAHA.117.10205","volume":"71","author":"K Kobuke","year":"2018","unstructured":"Kobuke, K. et al. Calneuron 1 Increased Ca2+ in the endoplasmic reticulum and aldosterone production in aldosterone-producing adenoma. Hypertension 71, 125\u2013133 (2018).","journal-title":"Hypertension"},{"key":"753_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","volume":"411","author":"S Monticone","year":"2015","unstructured":"Monticone, S. et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol. Cell Endocrinol. 411, 146\u2013154 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"753_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1530\/ERC-15-0321","volume":"22","author":"T \u00c5kerstr\u00f6m","year":"2015","unstructured":"\u00c5kerstr\u00f6m, T. et al. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. Endocr. Relat. Cancer 22, 735\u2013744 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"753_CR26","first-page":"621","volume":"115","author":"M Takeda","year":"1994","unstructured":"Takeda, M., Go, H., Imai, T., Nishiyama, T. & Morishita, H. Laparoscopic adrenalectomy for primary aldosteronism: report of initial ten cases. Surgery 115, 621\u2013625 (1994).","journal-title":"Surgery"},{"key":"753_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2214\/ajr.160.2.8424342","volume":"160","author":"NR Dunnick","year":"1993","unstructured":"Dunnick, N. R. et al. CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. AJR Am. J. Roentgenol. 160, 321\u2013324 (1993).","journal-title":"AJR Am. J. Roentgenol."},{"key":"753_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young, W. F. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227\u20131235 (2004).","journal-title":"Surgery"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR30","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu, K. et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch. Intern. Med. 141, 1589\u20131593 (1981).","journal-title":"Arch. Intern. Med."},{"key":"753_CR31","doi-asserted-by":"publisher","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","volume":"304","author":"R Gros","year":"2013","unstructured":"Gros, R., Ding, Q., Liu, B., Chorazyczewski, J. & Feldman, R. D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 304, C532\u2013C540 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"753_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00424-014-1658-0","volume":"467","author":"JW Funder","year":"2015","unstructured":"Funder, J. W. Primary aldosteronism and salt. Pflugers Arch. 467, 587\u2013594 (2015).","journal-title":"Pflugers Arch."},{"key":"753_CR33","doi-asserted-by":"crossref","unstructured":"Funder, J. in Stress: Neuroendocrinology and Neurobiology 221\u2013225 (Academic Press, 2017).","DOI":"10.1016\/B978-0-12-802175-0.00021-8"},{"key":"753_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown, J. M. et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann. Intern. Med. 173, 10\u201320 (2020).","journal-title":"Ann. Intern. Med."},{"key":"753_CR35","unstructured":"Drake, W. M. & Brown, M. J. in Oxford Textbook of Endocrinology and Diabetes 3rd edition (eds Wass, J. A. H. et al.) (Oxford University Press, 2022)."},{"key":"753_CR36","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1210\/jc.2009-2010","volume":"95","author":"K Nishimoto","year":"2010","unstructured":"Nishimoto, K. et al. Adrenocortical zonation in humans under normal and pathological conditions. J. Clin. Endocrinol. Metab. 95, 2296\u20132305 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MED.0000000000000248","volume":"23","author":"CE Gomez-Sanchez","year":"2016","unstructured":"Gomez-Sanchez, C. E. & Gomez-Sanchez, E. P. Immunohistochemistry of the adrenal in primary aldosteronism. Curr. Opin. Endocrinol. Diabetes Obes. 23, 242\u2013248 (2016).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"753_CR38","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata, K. et al. Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72, 874\u2013880 (2018).","journal-title":"Hypertension"},{"key":"753_CR39","doi-asserted-by":"publisher","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","volume":"364","author":"K Yizhak","year":"2019","unstructured":"Yizhak, K. et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science 364, eaaw0726 (2019).","journal-title":"Science"},{"key":"753_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton, R. P. et al. A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262\u2013265 (1992).","journal-title":"Nature"},{"key":"753_CR41","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"Geller, D. S. et al. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 93, 3117\u20133123 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton, T. J. et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas. J. Clin. Endocrinol. Metab. 97, 100\u2013109 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR43","doi-asserted-by":"publisher","unstructured":"Laycock, K. et al. \u2018Pseudo-failure\u2019 of adrenal vein sampling due to cortisol co-secretion by KCNJ5-mutant adenoma, and prediction of complete clinical success by urine hybrid steroid assay. Endocrine Abstracts https:\/\/doi.org\/10.1530\/endoabs.91.OC1 (2023).","DOI":"10.1530\/endoabs.91.OC1"},{"key":"753_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","volume":"59","author":"M Yamada","year":"2012","unstructured":"Yamada, M. et al. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735\u2013741 (2012).","journal-title":"Endocr. J."},{"key":"753_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/en.2013-1733","volume":"155","author":"CE Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez, C. E. & Oki, K. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? Endocrinology 155, 47\u201355 (2014).","journal-title":"Endocrinology"},{"key":"753_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mce.2015.09.011","volume":"417","author":"AX Chen","year":"2015","unstructured":"Chen, A. X., Nishimoto, K., Nanba, K. & Rainey, W. E. Potassium channels related to primary aldosteronism: expression similarities and differences between human and rat adrenals. Mol. Cell Endocrinol. 417, 141\u2013148 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"753_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/ajh\/hpz172","volume":"33","author":"AG Maria","year":"2020","unstructured":"Maria, A. G. et al. Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia. Am. J. Hypertens. 33, 124\u2013130 (2020).","journal-title":"Am. J. Hypertens."},{"key":"753_CR48","doi-asserted-by":"publisher","first-page":"E155","DOI":"10.1210\/jc.2014-3009","volume":"100","author":"CJ Cheng","year":"2015","unstructured":"Cheng, C. J. et al. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. J. Clin. Endocrinol. Metab. 100, E155\u2013E163 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR49","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1097\/HJH.0b013e328356139f","volume":"30","author":"M Murthy","year":"2012","unstructured":"Murthy, M., Azizan, E. A., Brown, M. J. & O\u2019Shaughnessy, K. M. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J. Hypertens. 30, 1827\u20131833 (2012).","journal-title":"J. Hypertens."},{"key":"753_CR50","doi-asserted-by":"publisher","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","volume":"97","author":"E Charmandari","year":"2012","unstructured":"Charmandari, E. et al. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J. Clin. Endocrinol. Metab. 97, E1532\u2013E1539 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR51","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/jhh.2017.50","volume":"31","author":"FF Zheng","year":"2017","unstructured":"Zheng, F. F. et al. A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production. J. Hum. Hypertens. 31, 756\u2013759 (2017).","journal-title":"J. Hum. Hypertens."},{"key":"753_CR52","doi-asserted-by":"publisher","first-page":"E1765","DOI":"10.1210\/jc.2014-1927","volume":"99","author":"M Kuppusamy","year":"2014","unstructured":"Kuppusamy, M. et al. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium. J. Clin. Endocrinol. Metab. 99, E1765\u2013E1773 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/gs.2019.10.22","volume":"9","author":"J Rege","year":"2020","unstructured":"Rege, J., Turcu, A. F. & Rainey, W. E. Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas. Gland. Surg. 9, 3\u201313 (2020).","journal-title":"Gland. Surg."},{"key":"753_CR54","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","volume":"109","author":"UI Scholl","year":"2012","unstructured":"Scholl, U. I. et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl Acad. Sci. USA 109, 2533\u20132538 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"753_CR55","doi-asserted-by":"publisher","first-page":"E114","DOI":"10.1210\/jc.2014-3636","volume":"100","author":"S Monticone","year":"2015","unstructured":"Monticone, S. et al. A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue. J. Clin. Endocrinol. Metab. 100, E114\u2013E118 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","volume":"59","author":"P Mulatero","year":"2012","unstructured":"Mulatero, P. et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59, 235\u2013240 (2012).","journal-title":"Hypertension"},{"key":"753_CR57","doi-asserted-by":"publisher","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","volume":"98","author":"S Monticone","year":"2013","unstructured":"Monticone, S. et al. A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J. Clin. Endocrinol. Metab. 98, E1861\u2013E1865 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR58","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","volume":"100","author":"L Lenzini","year":"2015","unstructured":"Lenzini, L. et al. A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 100, E1089\u2013E1095 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR59","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000708","volume":"94","author":"B Wang","year":"2015","unstructured":"Wang, B. et al. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients. Medicine 94, e708 (2015).","journal-title":"Medicine"},{"key":"753_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","volume":"73","author":"K Nanba","year":"2019","unstructured":"Nanba, K. et al. Genetic characteristics of aldosterone-producing adenomas in Blacks. Hypertension 73, 885\u2013892 (2019).","journal-title":"Hypertension"},{"key":"753_CR61","doi-asserted-by":"crossref","unstructured":"Azizan, E. et al. Half of an unselected series of aldosterone-producing adenomas have somatic mutation of the KCNJ5 channel and a zona fasciculata profile. J. Hum. Hypertens. 25, 627 (2011).","DOI":"10.1210\/endo-meetings.2011.PART2.P20.P1-783"},{"key":"753_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1507\/endocrj.EJ16-0243","volume":"64","author":"T Okamura","year":"2017","unstructured":"Okamura, T. et al. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations. Endocr. J. 64, 39\u201347 (2017).","journal-title":"Endocr. J."},{"key":"753_CR63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. [(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat. Med. 29, 190\u2013202 (2023).","journal-title":"Nat. Med."},{"key":"753_CR64","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/HYPERTENSIONAHA.116.08033","volume":"68","author":"J Zhou","year":"2016","unstructured":"Zhou, J. et al. Transcriptome pathway analysis of pathological and physiological aldosterone-producing human tissues. Hypertension 68, 1424\u20131431 (2016).","journal-title":"Hypertension"},{"key":"753_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/HYPERTENSIONAHA.117.09231","volume":"70","author":"C Maniero","year":"2017","unstructured":"Maniero, C. et al. NEFM (Neurofilament Medium) Polypeptide, a marker for zona glomerulosa cells in human adrenal, inhibits D1R (Dopamine D1 Receptor)-mediated secretion of aldosterone. Hypertension 70, 357\u2013364 (2017).","journal-title":"Hypertension"},{"key":"753_CR66","unstructured":"Maniero, C. A functional study on novel genes involved in regulating aldosterone secretion in normal human zona glomerulosa and in aldosterone-producing adenomas. Doctoral dissertation, University of Cambridge (2017)."},{"key":"753_CR67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein, F. et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat. Genet. 45, 440\u2013444 (2013). 444e1\u20132.","journal-title":"Nat. Genet."},{"key":"753_CR68","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1210\/en.2015-1466","volume":"156","author":"J Stindl","year":"2015","unstructured":"Stindl, J. et al. Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na+\/K+-ATPase. Endocrinology 156, 4582\u20134591 (2015).","journal-title":"Endocrinology"},{"key":"753_CR69","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1085\/jgp.201711827","volume":"149","author":"DJ Meyer","year":"2017","unstructured":"Meyer, D. J., Gatto, C. & Artigas, P. On the effect of hyperaldosteronism-inducing mutations in Na\/K pumps. J. Gen. Physiol. 149, 1009\u20131028 (2017).","journal-title":"J. Gen. Physiol."},{"key":"753_CR70","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajhg.2018.10.004","volume":"103","author":"KP Schlingmann","year":"2018","unstructured":"Schlingmann, K. P. et al. Germline de novo mutations in ATP1A1 cause renal hypomagnesemia, refractory seizures, and intellectual disability. Am. J. Hum. Genet. 103, 808\u2013816 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"753_CR71","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/cge.13668","volume":"97","author":"F Stregapede","year":"2020","unstructured":"Stregapede, F. et al. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation. Clin. Genet. 97, 521\u2013526 (2020).","journal-title":"Clin. Genet."},{"key":"753_CR72","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","volume":"63","author":"TA Williams","year":"2014","unstructured":"Williams, T. A. et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 63, 188\u2013195 (2014).","journal-title":"Hypertension"},{"key":"753_CR73","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1210\/en.2015-2029","volume":"157","author":"P Tauber","year":"2016","unstructured":"Tauber, P. et al. Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca2+-ATPase ATP2B3. Endocrinology 157, 2489\u20132499 (2016).","journal-title":"Endocrinology"},{"key":"753_CR74","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1073\/pnas.1207488109","volume":"109","author":"G Zanni","year":"2012","unstructured":"Zanni, G. et al. Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+ homeostasis. Proc. Natl Acad. Sci. USA 109, 14514\u201314519 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"753_CR75","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl, U. I. et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat. Genet. 45, 1050\u20131054 (2013).","journal-title":"Nat. Genet."},{"key":"753_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neulet.2010.08.085","volume":"486","author":"WA Catterall","year":"2010","unstructured":"Catterall, W. A. Signaling complexes of voltage-gated sodium and calcium channels. Neurosci. Lett. 486, 107\u2013116 (2010).","journal-title":"Neurosci. Lett."},{"key":"753_CR77","doi-asserted-by":"publisher","first-page":"R437","DOI":"10.1530\/ERC-16-0055","volume":"23","author":"RK Dutta","year":"2016","unstructured":"Dutta, R. K., S\u00f6derkvist, P. & Gimm, O. Genetics of primary hyperaldosteronism. Endocr. Relat. Cancer 23, R437\u2013R454 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"753_CR78","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MED.0000000000000255","volume":"23","author":"EA Azizan","year":"2016","unstructured":"Azizan, E. A. & Brown, M. J. Novel genetic determinants of adrenal aldosterone regulation. Curr. Opin. Endocrinol. Diabetes Obes. 23, 209\u2013217 (2016).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"753_CR79","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1055\/s-0035-1564166","volume":"47","author":"HE Korah","year":"2015","unstructured":"Korah, H. E. & Scholl, U. I. an update on familial hyperaldosteronism. Horm. Metab. Res. 47, 941\u2013946 (2015).","journal-title":"Horm. Metab. Res."},{"key":"753_CR80","doi-asserted-by":"publisher","first-page":"816476","DOI":"10.3389\/fendo.2022.816476","volume":"13","author":"CS Tseng","year":"2022","unstructured":"Tseng, C. S. et al. A novel somatic mutation of CACNA1H p.V1937M in unilateral primary hyperaldosteronism. Front. Endocrinol. 13, 816476 (2022).","journal-title":"Front. Endocrinol."},{"key":"753_CR81","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","volume":"75","author":"K Nanba","year":"2020","unstructured":"Nanba, K. et al. Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma. Hypertension 75, 645\u2013649 (2020).","journal-title":"Hypertension"},{"key":"753_CR82","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","volume":"4","author":"UI Scholl","year":"2015","unstructured":"Scholl, U. I. et al. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4, e06315 (2015).","journal-title":"Elife"},{"key":"753_CR83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl, U. I. et al. CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat. Genet. 50, 349\u2013354 (2018).","journal-title":"Nat. Genet."},{"key":"753_CR84","doi-asserted-by":"publisher","first-page":"bvaa123","DOI":"10.1210\/jendso\/bvaa123","volume":"4","author":"J Rege","year":"2020","unstructured":"Rege, J. et al. Identification of somatic mutations in CLCN2 in aldosterone-producing adenomas. J. Endocr. Soc. 4, bvaa123 (2020).","journal-title":"J. Endocr. Soc."},{"key":"753_CR85","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","volume":"50","author":"FL Fernandes-Rosa","year":"2018","unstructured":"Fernandes-Rosa, F. L. et al. A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat. Genet. 50, 355\u2013361 (2018).","journal-title":"Nat. Genet."},{"key":"753_CR86","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1530\/EJE-19-0377","volume":"181","author":"RK Dutta","year":"2019","unstructured":"Dutta, R. K. et al. A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma. Eur. J. Endocrinol. 181, K37\u2013K41 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"753_CR87","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","volume":"373","author":"AE Teo","year":"2015","unstructured":"Teo, A. E. et al. Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373, 1429\u20131436 (2015).","journal-title":"N. Engl. J. Med."},{"key":"753_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41525-2","volume":"9","author":"S Backman","year":"2019","unstructured":"Backman, S. et al. RNA sequencing provides novel insights into the transcriptome of aldosterone producing adenomas. Sci. Rep. 9, 6269 (2019).","journal-title":"Sci. Rep."},{"key":"753_CR89","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","volume":"53","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat. Genet. 53, 1360\u20131372 (2021).","journal-title":"Nat. Genet."},{"key":"753_CR90","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ajhg.2016.05.010","volume":"98","author":"UM Ayturk","year":"2016","unstructured":"Ayturk, U. M. et al. Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am. J. Hum. Genet. 98, 1271 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"753_CR91","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191\u20132199 (2010).","journal-title":"N. Engl. J. Med."},{"key":"753_CR92","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","volume":"368","author":"MD Shirley","year":"2013","unstructured":"Shirley, M. D. et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N. Engl. J. Med. 368, 1971\u20131979 (2013).","journal-title":"N. Engl. J. Med."},{"key":"753_CR93","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1210\/jc.2005-1298","volume":"91","author":"K Saner-Amigh","year":"2006","unstructured":"Saner-Amigh, K. et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 91, 1136\u20131142 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR94","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/hmg\/ddl430","volume":"15","author":"RA Rey","year":"2006","unstructured":"Rey, R. A. et al. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum. Mol. Genet. 15, 3538\u20133543 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"753_CR95","unstructured":"Wu, X. et al. Somatic intramembranous mutations of CADM1 in aldosterone-producing adenomas, and gap junction-dependent regulation of aldosterone production. Nat. Genet. (2023)."},{"key":"753_CR96","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.devbrainres.2004.10.015","volume":"154","author":"E Fujita","year":"2005","unstructured":"Fujita, E., Urase, K., Soyama, A., Kouroku, Y. & Momoi, T. Distribution of RA175\/TSLC1\/SynCAM, a member of the immunoglobulin superfamily, in the developing nervous system. Brain Res. Dev. Brain Res. 154, 199\u2013209 (2005).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"753_CR97","doi-asserted-by":"publisher","first-page":"35386","DOI":"10.1074\/jbc.M110.129288","volume":"285","author":"C Crumbley","year":"2010","unstructured":"Crumbley, C., Wang, Y., Kojetin, D. J. & Burris, T. P. Characterization of the core mammalian clock component, NPAS2, as a REV-ERB\u03b1\/ROR\u03b1 target gene. J. Biol. Chem. 285, 35386\u201335392 (2010).","journal-title":"J. Biol. Chem."},{"key":"753_CR98","doi-asserted-by":"crossref","unstructured":"Laposky, A. & Turek, F. in Encyclopedia of Neuroscience 909\u2013914 (Elsevier, 2009).","DOI":"10.1016\/B978-008045046-9.01603-X"},{"key":"753_CR99","unstructured":"Upton, T. J. U-RHYTHM microdialysis: towards ambulatory metabolodynamics. Doctoral dissertation, University of Otago (2021)."},{"key":"753_CR100","doi-asserted-by":"publisher","unstructured":"Rege, J. et al. Zinc transporter somatic gene mutations cause primary aldosteronism. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.07.25.501443 (2022).","DOI":"10.1101\/2022.07.25.501443"},{"key":"753_CR101","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","volume":"59","author":"TA Williams","year":"2012","unstructured":"Williams, T. A. et al. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 59, 833\u2013839 (2012).","journal-title":"Hypertension"},{"key":"753_CR102","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1530\/JME-13-0248","volume":"52","author":"SJ Felizola","year":"2014","unstructured":"Felizola, S. J. et al. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J. Mol. Endocrinol. 52, 159\u2013167 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"753_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.peptides.2014.10.017","volume":"63","author":"M Trejter","year":"2015","unstructured":"Trejter, M. et al. Visinin-like peptide 1 in adrenal gland of the rat. Gene expression and its hormonal control. Peptides 63, 22\u201329 (2015).","journal-title":"Peptides"},{"key":"753_CR104","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/HYP.0000000000000025","volume":"65","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-\u03b2 signaling and suppresses aldosterone secretion. Hypertension 65, 1103\u20131110 (2015).","journal-title":"Hypertension"},{"key":"753_CR105","doi-asserted-by":"publisher","first-page":"E836","DOI":"10.1210\/jc.2015-1734","volume":"100","author":"LH Shaikh","year":"2015","unstructured":"Shaikh, L. H. et al. LGR5 activates noncanonical wnt signaling and inhibits aldosterone production in the human adrenal. J. Clin. Endocrinol. Metab. 100, E836\u2013E844 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR106","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.117.09156","volume":"69","author":"AE Teo","year":"2017","unstructured":"Teo, A. E. et al. Physiological and pathological roles in human adrenal of the glomeruli-defining matrix protein NPNT (Nephronectin). Hypertension 69, 1207\u20131216 (2017).","journal-title":"Hypertension"},{"key":"753_CR107","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto, K. et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc. Natl Acad. Sci. USA 112, E4591\u2013E4599 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"753_CR108","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.119.13287","volume":"74","author":"C Maniero","year":"2019","unstructured":"Maniero, C. et al. ANO4 (Anoctamin 4) is a novel marker of zona glomerulosa that regulates stimulated aldosterone secretion. Hypertension 74, 1152\u20131159 (2019).","journal-title":"Hypertension"},{"key":"753_CR109","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003\u20131007 (2007).","journal-title":"Nature"},{"key":"753_CR110","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1101\/gad.277756.116","volume":"30","author":"V Vidal","year":"2016","unstructured":"Vidal, V. et al. The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3. Genes. Dev. 30, 1389\u20131394 (2016).","journal-title":"Genes. Dev."},{"key":"753_CR111","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","volume":"136","author":"K Nanba","year":"2017","unstructured":"Nanba, K. et al. Age-related autonomous aldosteronism. Circulation 136, 347\u2013355 (2017).","journal-title":"Circulation"},{"key":"753_CR112","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1161\/HYPERTENSIONAHA.122.19052","volume":"79","author":"E van de Wiel","year":"2022","unstructured":"van de Wiel, E. et al. Changes of the CYP11B2 expressing zona glomerulosa in human adrenals from birth to 40 years of age. Hypertension 79, 2565\u20132572 (2022).","journal-title":"Hypertension"},{"key":"753_CR113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164915","volume":"133","author":"C Lucas","year":"2023","unstructured":"Lucas, C. et al. Loss of LGR4\/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation. J. Clin. Invest. 133, e164915 (2023).","journal-title":"J. Clin. Invest."},{"key":"753_CR114","doi-asserted-by":"publisher","first-page":"105361","DOI":"10.1016\/j.jsbmb.2019.04.010","volume":"191","author":"T Hayashi","year":"2019","unstructured":"Hayashi, T. et al. Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity. J. Steroid Biochem. Mol. Biol. 191, 105361 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"753_CR115","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","volume":"56","author":"S Boulkroun","year":"2010","unstructured":"Boulkroun, S. et al. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 56, 885\u2013892 (2010).","journal-title":"Hypertension"},{"key":"753_CR116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"Williams, T. A. et al. International histopathology consensus for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 106, 42\u201354 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR117","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","volume":"75","author":"N Sun","year":"2020","unstructured":"Sun, N. et al. Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism. Hypertension 75, 634\u2013644 (2020).","journal-title":"Hypertension"},{"key":"753_CR118","doi-asserted-by":"publisher","first-page":"OR09","DOI":"10.1210\/jendso\/bvaa046.885","volume":"4","author":"E Goodchild","year":"2020","unstructured":"Goodchild, E., Stoetaert, J., Drake, W., Linton, K. & Brown, M. J. OR09-05 expression of SLC35F1 in the plasma membrane of cells of aldosterone producing cell clusters (APCCs) and its possible role in aldosterone synthesis. J. Endocr. Soc. 4, OR09\u201305 (2020).","journal-title":"J. Endocr. Soc."},{"key":"753_CR119","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1210\/jc.2015-1268","volume":"100","author":"A Markou","year":"2015","unstructured":"Markou, A. et al. Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension. J. Clin. Endocrinol. Metab. 100, 2857\u20132864 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.116.07716","volume":"69","author":"K Bogman","year":"2017","unstructured":"Bogman, K. et al. Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2). Hypertension 69, 189\u2013196 (2017).","journal-title":"Hypertension"},{"key":"753_CR121","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","volume":"101","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto, K. et al. Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism. J. Clin. Endocrinol. Metab. 101, 6\u20139 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR122","doi-asserted-by":"publisher","first-page":"7834356","DOI":"10.1155\/2016\/7834356","volume":"2016","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto, K. et al. Human adrenocortical remodeling leading to aldosterone-producing cell cluster generation. Int. J. Endocrinol. 2016, 7834356 (2016).","journal-title":"Int. J. Endocrinol."},{"key":"753_CR123","doi-asserted-by":"publisher","first-page":"111296","DOI":"10.1016\/j.mce.2021.111296","volume":"530","author":"JE Baker","year":"2021","unstructured":"Baker, J. E. et al. Targeted RNA sequencing of adrenal zones using immunohistochemistry-guided capture of formalin-fixed paraffin-embedded tissue. Mol. Cell Endocrinol. 530, 111296 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"753_CR124","unstructured":"Gene Expression Omnibus. Series GSE68889. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE68889 (2023)."},{"key":"753_CR125","first-page":"1539","volume":"13","author":"I Ebermann","year":"2007","unstructured":"Ebermann, I. et al. Two truncating USH3A mutations, including one novel, in a German family with Usher syndrome. Mol. Vis. 13, 1539\u20131547 (2007).","journal-title":"Mol. Vis."},{"key":"753_CR126","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ophtha.2010.10.047","volume":"118","author":"MI Khan","year":"2011","unstructured":"Khan, M. I. et al. CLRN1 mutations cause nonsyndromic retinitis pigmentosa. Ophthalmology 118, 1444\u20131448 (2011).","journal-title":"Ophthalmology"},{"key":"753_CR127","first-page":"1598","volume":"17","author":"I Audo","year":"2011","unstructured":"Audo, I. et al. A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family. Mol. Vis. 17, 1598\u20131606 (2011).","journal-title":"Mol. Vis."},{"key":"753_CR128","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1167\/iovs.09-4650","volume":"51","author":"FF Kersten","year":"2010","unstructured":"Kersten, F. F. et al. Association of whirlin with Cav1.3 (\u03b11D) channels in photoreceptors, defining a novel member of the usher protein network. Invest. Ophthalmol. Vis. Sci. 51, 2338\u20132346 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"753_CR129","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0092-8674(00)00013-1","volume":"102","author":"J Platzer","year":"2000","unstructured":"Platzer, J. et al. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 102, 89\u201397 (2000).","journal-title":"Cell"},{"key":"753_CR130","doi-asserted-by":"publisher","first-page":"952055","DOI":"10.3389\/fendo.2022.952055","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai, Y. et al. Primary cilium in kidney development, function and disease. Front. Endocrinol. 13, 952055 (2022).","journal-title":"Front. Endocrinol."},{"key":"753_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-008-0071-4","volume":"13","author":"IS Mackenzie","year":"2009","unstructured":"Mackenzie, I. S. & Brown, M. J. Molecular and clinical investigations in patients with low-renin hypertension. Clin. Exp. Nephrol. 13, 1\u20138 (2009).","journal-title":"Clin. Exp. Nephrol."},{"key":"753_CR132","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3109\/07435809809032695","volume":"24","author":"G Arnaldi","year":"1998","unstructured":"Arnaldi, G. et al. ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. Endocr. Res. 24, 845\u2013849 (1998).","journal-title":"Endocr. Res."},{"key":"753_CR133","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1210\/jc.2005-1309","volume":"90","author":"G Assi\u00e9","year":"2005","unstructured":"Assi\u00e9, G. et al. Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. J. Clin. Endocrinol. Metab. 90, 6638\u20136649 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR134","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1210\/jc.2005-0836","volume":"90","author":"MH Bassett","year":"2005","unstructured":"Bassett, M. H. et al. Expression profiles for steroidogenic enzymes in adrenocortical disease. J. Clin. Endocrinol. Metab. 90, 5446\u20135455 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"753_CR135","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1530\/eje.0.1470795","volume":"147","author":"F Fallo","year":"2002","unstructured":"Fallo, F. et al. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur. J. Endocrinol. 147, 795\u2013802 (2002).","journal-title":"Eur. J. Endocrinol."},{"key":"753_CR136","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1365-2265.2001.01253.x","volume":"54","author":"B Schubert","year":"2001","unstructured":"Schubert, B. et al. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clin. Endocrinol. 54, 627\u2013632 (2001).","journal-title":"Clin. Endocrinol."},{"key":"753_CR137","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/HYPERTENSIONAHA.110.150318","volume":"55","author":"TA Williams","year":"2010","unstructured":"Williams, T. A. et al. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension 55, 1468\u20131475 (2010).","journal-title":"Hypertension"},{"key":"753_CR138","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1677\/JOE-07-0037","volume":"195","author":"P Ye","year":"2007","unstructured":"Ye, P., Mariniello, B., Mantero, F., Shibata, H. & Rainey, W. E. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J. Endocrinol. 195, 39\u201348 (2007).","journal-title":"J. Endocrinol."},{"key":"753_CR139","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/HYPERTENSIONAHA.120.16774","volume":"77","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. BEX1 is differentially expressed in aldosterone-producing adenomas and protects human adrenocortical cells from ferroptosis. Hypertension 77, 1647\u20131658 (2021).","journal-title":"Hypertension"},{"key":"753_CR140","unstructured":"GTEx Portal. GTEx Analysis Release V8 (dbGaP Accession phs000424.v8.p2. https:\/\/gtexportal.org\/home\/gene\/KCNJ5 (2023)."},{"key":"753_CR141","doi-asserted-by":"publisher","unstructured":"Papp, F. et al. TMEM266 is a functional voltage sensor regulated by extracellular Zn(2). Elife 8 https:\/\/doi.org\/10.7554\/elife.42372 (2019).","DOI":"10.7554\/elife.42372"},{"key":"753_CR142","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1042\/BCJ20220033","volume":"479","author":"T Kawai","year":"2022","unstructured":"Kawai, T. et al. Insight into the function of a unique voltage-sensor protein (TMEM266) and its short form in mouse cerebellum. Biochem. J. 479, 1127\u20131145 (2022).","journal-title":"Biochem. J."},{"key":"753_CR143","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/HYPERTENSIONAHA.111.189662","volume":"59","author":"NA Guagliardo","year":"2012","unstructured":"Guagliardo, N. A. et al. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension 59, 999\u20131005 (2012).","journal-title":"Hypertension"},{"key":"753_CR144","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1113\/JP271896","volume":"594","author":"PQ Barrett","year":"2016","unstructured":"Barrett, P. Q. et al. Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex. J. Physiol. 594, 5851\u20135860 (2016).","journal-title":"J. Physiol."},{"key":"753_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32896-8","volume":"13","author":"E Le Floch","year":"2022","unstructured":"Le Floch, E. et al. Identification of risk loci for primary aldosteronism in genome-wide association studies. Nat. Commun. 13, 5198 (2022).","journal-title":"Nat. Commun."},{"key":"753_CR146","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/07435809609043748","volume":"22","author":"A Sp\u00e4t","year":"1996","unstructured":"Sp\u00e4t, A., Roh\u00e1cs, T., Horv\u00e1th, A., Szabadkai, G. & Enyedi, P. The role of voltage-dependent calcium channels in angiotensin-stimulated glomerulosa cells. Endocr. Res. 22, 569\u2013576 (1996).","journal-title":"Endocr. Res."},{"key":"753_CR147","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1073\/pnas.0712000105","volume":"105","author":"LA Davies","year":"2008","unstructured":"Davies, L. A. et al. TASK channel deletion in mice causes primary hyperaldosteronism. Proc. Natl Acad. Sci. USA 105, 2203\u20132208 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"753_CR148","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11906-022-01176-7","volume":"24","author":"T Wannachalee","year":"2022","unstructured":"Wannachalee, T., Lieberman, L. & Turcu, A. F. High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it. Curr. Hypertens. Rep. 24, 123\u2013132 (2022).","journal-title":"Curr. Hypertens. Rep."},{"key":"753_CR149","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00259-022-05957-9","volume":"50","author":"I Silins","year":"2023","unstructured":"Silins, I. et al. First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours. Eur. J. Nucl. Med Mol. Imaging 50, 398\u2013409 (2023).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"753_CR150","unstructured":"Goodchild, E. et al. in Endocrine Abstracts Vol. 86 (Bioscientifica, 2022)."},{"key":"753_CR151","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1021\/acs.jmedchem.1c00539","volume":"64","author":"K Sander","year":"2021","unstructured":"Sander, K. et al. Development of [18F]aldoview as the first highly selective aldosterone synthase pet tracer for imaging of primary hyperaldosteronism. J. Med. Chem. 64, 9321\u20139329 (2021).","journal-title":"J. Med. Chem."},{"key":"753_CR152","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw. Open. 6, e2255609 (2023).","journal-title":"JAMA Netw. Open."},{"key":"753_CR153","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tins.2022.03.004","volume":"45","author":"MD Mart\u00edn-de-Saavedra","year":"2022","unstructured":"Mart\u00edn-de-Saavedra, M. D., Santos, M. D. & Penzes, P. Intercellular signaling by ectodomain shedding at the synapse. Trends Neurosci. 45, 483\u2013498 (2022).","journal-title":"Trends Neurosci."},{"key":"753_CR154","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s13304-021-01069-5","volume":"73","author":"RQ Guo","year":"2021","unstructured":"Guo, R. Q., Li, Y. M. & Li, X. G. Comparison of the radiofrequency ablation versus laparoscopic adrenalectomy for aldosterone-producing adenoma: a meta-analysis of perioperative outcomes and safety. Updates Surg. 73, 1477\u20131485 (2021).","journal-title":"Updates Surg."},{"key":"753_CR155","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jvir.2015.11.034","volume":"27","author":"FJ Fintelmann","year":"2016","unstructured":"Fintelmann, F. J. et al. Catecholamine surge during image-guided ablation of adrenal gland metastases: predictors, consequences, and recommendations for management. J. Vasc. Interv. Radiol. 27, 395\u2013402 (2016).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"753_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18136-5","volume":"12","author":"S Oguro","year":"2022","unstructured":"Oguro, S. et al. Safety and feasibility of radiofrequency ablation using bipolar electrodes for aldosterone-producing adenoma: a multicentric prospective clinical study. Sci. Rep. 12, 14090 (2022).","journal-title":"Sci. Rep."},{"key":"753_CR157","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation 144, 580\u2013582 (2021).","journal-title":"Circulation"},{"key":"753_CR158","unstructured":"Argentesi, G. et al. in Endocrine Abstracts Vol. 86 (Bioscientifica, 2022)."},{"key":"753_CR159","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05405101 (2023)."},{"key":"753_CR160","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/pgmj.75.882.235","volume":"75","author":"MJ Brown","year":"1999","unstructured":"Brown, M. J. & Hopper, R. V. Calcium-channel blockade can mask the diagnosis of Conn\u2019s syndrome. Postgrad. Med. J. 75, 235\u2013236 (1999).","journal-title":"Postgrad. Med. J."},{"key":"753_CR161","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1210\/en.2004-1102","volume":"146","author":"G Lee","year":"2005","unstructured":"Lee, G. et al. Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. Endocrinology 146, 2650\u20132656 (2005).","journal-title":"Endocrinology"},{"key":"753_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2149","volume":"3","author":"S Kang","year":"2012","unstructured":"Kang, S. et al. CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson\u2019s disease. Nat. Commun. 3, 1146 (2012).","journal-title":"Nat. Commun."},{"key":"753_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/srep24697","volume":"6","author":"CB Xie","year":"2016","unstructured":"Xie, C. B. et al. Regulation of aldosterone secretion by Cav1.3. Sci. Rep. 6, 24697 (2016).","journal-title":"Sci. Rep."},{"key":"753_CR164","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1172\/JCI91733","volume":"127","author":"UI Scholl","year":"2017","unstructured":"Scholl, U. I. et al. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J. Clin. Invest. 127, 2739\u20132750 (2017).","journal-title":"J. Clin. Invest."},{"key":"753_CR165","doi-asserted-by":"publisher","first-page":"eabn8485","DOI":"10.1126\/sciadv.abn8485","volume":"8","author":"K Cheng","year":"2022","unstructured":"Cheng, K. et al. The developmental origin and the specification of the adrenal cortex in humans and cynomolgus monkeys. Sci. Adv. 8, eabn8485 (2022).","journal-title":"Sci. Adv."},{"key":"753_CR166","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.devcel.2013.07.016","volume":"26","author":"BD Freedman","year":"2013","unstructured":"Freedman, B. D. et al. Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells. Dev. Cell 26, 666\u2013673 (2013).","journal-title":"Dev. Cell"},{"key":"753_CR167","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cell.2019.01.022","volume":"176","author":"LS Ludwig","year":"2019","unstructured":"Ludwig, L. S. et al. Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics. Cell 176, 1325\u20131339.e22 (2019).","journal-title":"Cell"},{"key":"753_CR168","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/genes12101558","volume":"12","author":"MP N","year":"2021","unstructured":"N, M. P. et al. Improved SNV discovery in barcode-stratified scRNA-seq alignments. Genes 12, 1558 (2021).","journal-title":"Genes"},{"key":"753_CR169","doi-asserted-by":"publisher","first-page":"111258","DOI":"10.1016\/j.mce.2021.111258","volume":"528","author":"N Bechmann","year":"2021","unstructured":"Bechmann, N., Berger, I., Bornstein, S. R. & Steenblock, C. Adrenal medulla development and medullary-cortical interactions. Mol. Cell Endocrinol. 528, 111258 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"753_CR170","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/(SICI)1097-0029(19970315)36:6<520::AID-JEMT9>3.0.CO;2-L","volume":"36","author":"SR Bornstein","year":"1997","unstructured":"Bornstein, S. R., Ehrhart-Bornstein, M. & Scherbaum, W. A. Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland. Microsc. Res. Tech. 36, 520\u2013533 (1997).","journal-title":"Microsc. Res. Tech."},{"key":"753_CR171","doi-asserted-by":"publisher","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","volume":"284","author":"JM Brittain","year":"2009","unstructured":"Brittain, J. M. et al. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J. Biol. Chem. 284, 31375\u201331390 (2009).","journal-title":"J. Biol. Chem."},{"key":"753_CR172","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00018-011-0843-y","volume":"69","author":"BA Simms","year":"2012","unstructured":"Simms, B. A. & Zamponi, G. W. Trafficking and stability of voltage-gated calcium channels. Cell Mol. Life Sci. 69, 843\u2013856 (2012).","journal-title":"Cell Mol. Life Sci."},{"key":"753_CR173","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104369","volume":"39","author":"T Di Mattia","year":"2020","unstructured":"Di Mattia, T. et al. FFAT motif phosphorylation controls formation and lipid transfer function of inter-organelle contacts. EMBO J. 39, e104369 (2020).","journal-title":"EMBO J."},{"key":"753_CR174","doi-asserted-by":"publisher","first-page":"24534","DOI":"10.1073\/pnas.2013762117","volume":"117","author":"S Gu","year":"2020","unstructured":"Gu, S. et al. Hair cell \u03b19\u03b110 nicotinic acetylcholine receptor functional expression regulated by ligand binding and deafness gene products. Proc. Natl Acad. Sci. USA 117, 24534\u201324544 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"753_CR175","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa2213169","volume":"388","author":"MW Freeman","year":"2022","unstructured":"Freeman, M. W. et al. Phase 2 trial of baxdrostat for treatment-resistant hypertension. N. Engl. J. Med 388, 395\u2013405 (2022).","journal-title":"N. Engl. J. Med"},{"key":"753_CR176","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41422-022-00663-5","volume":"32","author":"X Yao","year":"2022","unstructured":"Yao, X., Gao, S. & Yan, N. Structural basis for pore blockade of human voltage-gated calcium channel Ca(v)1.3 by motion sickness drug cinnarizine. Cell Res. 32, 946\u2013948 (2022).","journal-title":"Cell Res."},{"key":"753_CR177","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12022-015-9366-7","volume":"26","author":"SJ Felizola","year":"2015","unstructured":"Felizola, S. J. et al. Pre-B lymphocyte protein 3 (VPREB3) expression in the adrenal cortex: precedent for non-immunological roles in normal and neoplastic human tissues. Endocr. Pathol. 26, 119\u2013128 (2015).","journal-title":"Endocr. Pathol."},{"key":"753_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007381","volume":"14","author":"MF Guiraldelli","year":"2018","unstructured":"Guiraldelli, M. F. et al. SHOC1 is a ERCC4-(HhH)2-like protein, integral to the formation of crossover recombination intermediates during mammalian meiosis. PLoS Genet. 14, e1007381 (2018).","journal-title":"PLoS Genet."},{"key":"753_CR179","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1095\/biolreprod.116.145458","volume":"96","author":"T Iwamori","year":"2017","unstructured":"Iwamori, T., Iwamori, N., Matsumoto, M., Ono, E. & Matzuk, M. M. Identification of KIAA1210 as a novel X-chromosome-linked protein that localizes to the acrosome and associates with the ectoplasmic specialization in testes. Biol. Reprod. 96, 469\u2013477 (2017).","journal-title":"Biol. Reprod."},{"key":"753_CR180","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/biolre\/ioaa017","volume":"102","author":"T Iwamori","year":"2020","unstructured":"Iwamori, T., Iwamori, N., Matsumoto, M., Imai, H. & Ono, E. Novel localizations and interactions of intercellular bridge proteins revealed by proteomic profiling\u2020. Biol. Reprod. 102, 1134\u20131144 (2020).","journal-title":"Biol. Reprod."},{"key":"753_CR181","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrm1678","volume":"6","author":"BM Ogle","year":"2005","unstructured":"Ogle, B. M., Cascalho, M. & Platt, J. L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 6, 567\u2013575 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"753_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/srep36863","volume":"6","author":"F Sottile","year":"2016","unstructured":"Sottile, F., Aulicino, F., Theka, I. & Cosma, M. P. Mesenchymal stem cells generate distinct functional hybrids in vitro via cell fusion or entosis. Sci. Rep. 6, 36863 (2016).","journal-title":"Sci. Rep."},{"key":"753_CR183","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-06-1456","volume":"66","author":"BM Jacobsen","year":"2006","unstructured":"Jacobsen, B. M. et al. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res. 66, 8274\u20138279 (2006).","journal-title":"Cancer Res."},{"key":"753_CR184","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00018-004-4200-2","volume":"61","author":"K Mortensen","year":"2004","unstructured":"Mortensen, K., Lichtenberg, J., Thomsen, P. D. & Larsson, L. I. Spontaneous fusion between cancer cells and endothelial cells. Cell Mol. Life Sci. 61, 2125\u20132131 (2004).","journal-title":"Cell Mol. Life Sci."},{"key":"753_CR185","doi-asserted-by":"publisher","unstructured":"Pfannkuche, K. Preface. in Cell Fusion: Overviews and Methods https:\/\/doi.org\/10.1007\/978-1-4939-2703-6 (Humana, 2015).","DOI":"10.1007\/978-1-4939-2703-6"},{"key":"753_CR186","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3390\/ijms21051811","volume":"21","author":"J D\u00f6rnen","year":"2020","unstructured":"D\u00f6rnen, J., Sieler, M., Weiler, J., Keil, S. & Dittmar, T. Cell fusion-mediated tissue regeneration as an inducer of polyploidy and aneuploidy. Int. J. Mol. Sci. 21, 1811 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"753_CR187","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/endo-129-2-1113","volume":"129","author":"SR Bornstein","year":"1991","unstructured":"Bornstein, S. R., Ehrhart-Bornstein, M. & Scherbaum, W. A. Ultrastructural evidence for cortico-chromaffin hybrid cells in rat adrenals? Endocrinology 129, 1113\u20131115 (1991).","journal-title":"Endocrinology"},{"key":"753_CR188","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/03602530600570040","volume":"38","author":"I Hanukoglu","year":"2006","unstructured":"Hanukoglu, I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug. Metab. Rev. 38, 171\u2013196 (2006).","journal-title":"Drug. Metab. Rev."},{"key":"753_CR189","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1006\/jmbi.1999.2807","volume":"289","author":"GA Ziegler","year":"1999","unstructured":"Ziegler, G. A., Vonrhein, C., Hanukoglu, I. & Schulz, G. E. The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. J. Mol. Biol. 289, 981\u2013990 (1999).","journal-title":"J. Mol. Biol."},{"key":"753_CR190","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","volume":"68","author":"M Tadjine","year":"2008","unstructured":"Tadjine, M., Lampron, A., Ouadi, L. & Bourdeau, I. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin. Endocrinol. 68, 264\u2013270 (2008).","journal-title":"Clin. Endocrinol."},{"key":"753_CR191","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","volume":"3","author":"GL Hundemer","year":"2018","unstructured":"Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M. & Vaidya, A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol. 3, 768\u2013774 (2018).","journal-title":"JAMA Cardiol."},{"key":"753_CR192","unstructured":"GTEx Portal. GTEx analysis release V8 (dbGaP accession phs000424.v8.p2). https:\/\/gtexportal.org\/home\/gene\/KCNJ5 (accessed 10 April 2023)."},{"key":"753_CR193","unstructured":"RCSB Protein Data Bank. Crystal structure of the G protein-gated inward rectifier K+ channel GIRK2 (Kir3.2) in complex with sodium and PIP2. https:\/\/www.rcsb.org\/structure\/3SYA (2023)."},{"key":"753_CR194","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00424-020-02418-w","volume":"472","author":"NJ Ortner","year":"2020","unstructured":"Ortner, N. J. et al. De novo CACAN1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism. Pflugers Arch. 472, 755\u2013773 (2020).","journal-title":"Pflugers Arch."},{"key":"753_CR195","unstructured":"The Human Protein Atlas. SLC35F1. https:\/\/www.proteinatlas.org\/ENSG00000196376-SLC35F1\/tissue\/adrenal+gland#img (2023)."},{"key":"753_CR196","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"753_CR197","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","volume":"67","author":"TA Williams","year":"2016","unstructured":"Williams, T. A. et al. Genotype-specific steroid profiles associated with aldosterone-producing adenomas. Hypertension 67, 139\u2013145 (2016).","journal-title":"Hypertension"},{"key":"753_CR198","first-page":"1029","volume":"39","author":"TM Seccia","year":"2018","unstructured":"Seccia, T. M., Caroccia, B., Gomez-Sanchez, E. P., Gomez-Sanchez, C. E. & Rossi, G. P. The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications. Endocr. Rev. 39, 1029\u20131056 (2018).","journal-title":"Endocr. Rev."},{"key":"753_CR199","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1055\/s-0043-122602","volume":"49","author":"JWM Lenders","year":"2017","unstructured":"Lenders, J. W. M., Eisenhofer, G. & Reincke, M. Subtyping of patients with primary aldosteronism: an update. Horm. Metab. Res. 49, 922\u2013928 (2017).","journal-title":"Horm. Metab. Res."},{"key":"753_CR200","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","volume":"62","author":"G Eisenhofer","year":"2016","unstructured":"Eisenhofer, G. et al. Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin. Chem. 62, 514\u2013524 (2016).","journal-title":"Clin. Chem."},{"key":"753_CR201","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","volume":"65","author":"F Satoh","year":"2015","unstructured":"Satoh, F. et al. Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. Hypertension 65, 1096\u20131102 (2015).","journal-title":"Hypertension"},{"key":"753_CR202","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1210\/jc.2019-00531","volume":"104","author":"LAP Vilela","year":"2019","unstructured":"Vilela, L. A. P. et al. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 104, 4695\u20134702 (2019).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00753-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T12:04:44Z","timestamp":1700049884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00753-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":202,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1038\/s41581-023-00753-6","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"21 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}